DOREET NAGATTI: Open Payments
NPI 1508410275 · GREAT NECK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 29 payments from 9 companies in 2025. Trend: 2023 $122 · 2024 $585 · 2025 $852
Food & beverage: $852
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $224 |
| LEO Pharma Inc. | 6 | $207 |
| ABBVIE INC. | 11 | $182 |
| UCB, Inc. | 3 | $87 |
| Arcutis Biotherapeutics, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $40 |
| Organon LLC | 1 | $33 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: NEMLUVIO, ADBRY, Bimzelx, RINVOQ, BOTOX, Zoryve, CIBINQO, SKYRIZI.
Industry payments across NY — which companies pay providers there.
